Found 15 matching trials
Comparing ASCT Followed by Anti-BCMA CAR-T vs. ASCT Alone in NDMM Patients Eligible for ASCT PHASE2 This is a prospective study comparing autologous hematopoietic stem cell tr...
Show More Location
The Affiliated Hospital oh Xuzhou Medical University
Learn More & Join Trial
Bispecific Antibody-Based Salvage Therapy Followed by CAR-T ± ASCT in R/R Aggressive B-Cell Lymphoma PHASE2 This study consists of two sequential treatment phases. In the first phase,...
Show More Location
Institute of Hematology & Blood Diseases Hospital
Learn More & Join Trial
CAR-T-cell Treatment for Untreated High Risk MANtle Cell Lymphoma PHASE2 First-line CAR-T-cell consolidation after an abbreviated induction with 2 c...
Show More Location
University Hospital of Mainz
Learn More & Join Trial
A Phase III, Multicentre Study to Evaluate Consolidation Treatment With AZD0120 Compared With ASCT, in Participants With Newly Diagnosed Multiple Myeloma Who Are Transplant Eligible (DURGA-6). PHASE3 The purpose of this study is to measure the efficacy of AZD0120 compared wi...
Show More Learn More & Join Trial
Phase II Clinical Study on the Safety and Efficacy of Combined CAR-T Therapy Following Autologous Stem Cell Transplantation in Multiple Myeloma NA Chimeric Antigen Receptor T-Cell (CAR-T) immunotherapy is a rapidly develop...
Show More Location
The Affiliated Hospital of Xuzhou Medical University
Learn More & Join Trial
Efficacy of Sequential BCMA CAR-T Cell Therapy Following Autologous Hematopoietic Stem Cell Transplantation in Transplant-eligible Newly Diagnosed Multiple Myeloma PHASE1 1. Study Title A Single-Center, Open-Label, Single-Arm Clinical Study of Se...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of VRD-based Regimen Combined With CART-ASCT-CART2 Treatment in Patients With Primary Plasma Cell Leukemia PHASE2 This is a single-arm, open-label study to evaluate the efficacy and safety ...
Show More Status
Active Not Recruiting
Location
Institute of Hematology and Blood Diseases Hospital Chinese Academy of Medical Sciences
Learn More & Join Trial
Integrated Radiotherapy-optimized ASCT Sequential CAR-T Therapy for Patients With Relapsed and Refractory B-NHL NA This study aims to investigate a novel therapeutic strategy of integrated r...
Show More Location
the First Affiliated Hospital of Soochow University
Learn More & Join Trial
BCMA CAR-T Versus ASCT in Transplant-eligible Patients With Multiple Myeloma PHASE2 This is a prospective, non-inferiority study comparing VRD±D followed by BC...
Show More Location
Institute of Hematology and Blood Diseases Hospital Chinese Academy of Medical Sciences
Learn More & Join Trial
ASCT Combined With BCMA CAR-T and GPRC5D/CD3 BiTEs Maintenance for Transplant-Eligible Primary Plasma Cell Leukemia PHASE2 This is a prospective, single-arm, phase II study to evaluate the efficacy ...
Show More Location
Institute of Hematology and Blood Diseases Hospital Chinese Academy of Medical Sciences
Learn More & Join Trial